LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...

Omada Health has released new data indicating that its GLP-1 companion program significantly enhances medication persistence for GLP-1 treatments, which are linked to increased weight loss. The ...

Birth-related mortality is a major contributor to the burden of deaths worldwide, especially in low-income countries. The Safer Births Bundle of Care program is a combination of interventions ...

The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a ...